Teva to pay $85m to Oklahoma over opioid case | Financial Times
Teva's $6bn loss complicates search for a chief | Financial Times
Nobody Thought It Would Come to This': Drug Maker Teva Faces a Crisis - The New York Times
Drugmaker Teva fueled opioid addiction in New York, jury finds | Reuters
Teva Seeks New CFO as It Faces High Debt Levels, Opioid Litigation - WSJ
Teva Generic Medicines Saved the United States $28.8 Billion in 2020, and a Total of $43.1 Billion Across Major Markets, According to Independent Analysis | Business Wire
Opioid Crisis Deepens as Teva, Allergan Face Fraud Charges
Teva Reports First Quarter 2020 Financial Results | Business Wire
Will Teva Stock Rebound After A 10% Fall In A Month?
1 Healthcare Stock to Avoid in 2022 | The Motley Fool
Teva, Some Units Fueled Opioid Crisis, N.Y. Jury Concludes (2)
How much Teva's collapse has cost Israelis - and why it endangers the economy - Business - Haaretz.com
Teva Pharmaceuticals Found Liable For Opioid Crisis by Jury, Trial Will Determine Penalty
Teva: Definitely Undervalued (NYSE:TEVA) | Seeking Alpha
Will Teva Stock Rebound After A 10% Fall In A Month?
Teva, Units Held Liable for Fueling N.Y. Opioid Crisis
Teva to pay $85m to Oklahoma over opioid case | Financial Times
Teva Stock Offers Maximum Optimism For Investors (NYSE:TEVA) | Seeking Alpha
Teva Stock Offers Maximum Optimism For Investors (NYSE:TEVA) | Seeking Alpha
New York jury holds drug firm Teva liable in opioid crisis
Teva (TEVA) Stock Is Still Facing Major Risk at This Point | InvestorPlace
Teva: A Complete Overview (NYSE:TEVA) | Seeking Alpha
Teva sees higher margins, lower debt from restructuring | Financial Times
Teva sells its only manufacturing plant in Russia
Federal data reveals extent of Teva's role in fueling US opioid crisis | The Times of Israel
Teva shares surge after announcing global opioid settlement
Teva: Definitely Undervalued (NYSE:TEVA) | Seeking Alpha
